Company / Book Value per Share
Adaptimmune Therapeutics PLC Book Value per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.009
FY2024
5-year range
$0.009 / $0.541
FY2020-FY2024
Trend
-78.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has declined for 4 consecutive years, from $0.541 in FY2020 to $0.009 in FY2024.
Based on SEC 10-K filings.
$0.009 in FY2024 with a 5-year CAGR of -46.4%.
Declined from $0.088 to $0.009 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -66.0%
- 5-Year CAGR
- -46.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Adaptimmune Therapeutics PLC's book value per share has declined for 4 consecutive years.
- 5-year CAGR of -46.4%, indicating a declining trend.
- In FY2024, book value per share decreased 78.3% year-over-year.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.009 | -78.3% |
| FY2023 | $0.04 | -54.6% |
| FY2022 | $0.088 | -60.2% |
| FY2021 | $0.222 | -59.0% |
| FY2020 | $0.541 | +174.4% |
| FY2019 | $0.197 | -55.1% |
| FY2018 | $0.439 | -8.1% |
| FY2017 | $0.478 | +22.2% |
| FY2016 | $0.391 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026